Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Chronic Sinusitis and Facial Pain with Depression
NCT00754793Phase 4Terminated
- Sponsor
- University of Washington
- Start
- Jan 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in major depressive disorder (MDD), sponsored by University of Washington. Primary endpoint: Sino-Nasal Outcome Test-20 at 12 weeks. Started Jan 2009; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00754793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754793.